4Diefenbach A, Jamieson AM, Liu SD, et al. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages [J]. Nat Immunol. 2000, 1 (2): 119-126.
5DiefenbachA, Jensen ER, JamiesonAM, etal. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity [J].Nature, 2001, 413(6852): 165-171.
6Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cellmediated rejection of a MHC class I-bearing tumor in vivo[J].Proc Natl Acad Sci U S A, 2001, 98(20): 11521-11526.
7Gumperz JE, Miyake S, Yamamura T, et al. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining[J]. J Exp Med, 2002, 195(5): 625-636.
8Smyth MJ, Thia KY, Street SE, et al. Differential Tumor Surveillance by Natural Killer (NK) and NKT Cells[J]. J Exp Med,2000, 191(4) :661-668.
9Takeda K, Hayakawa Y, Atsuta M, et al. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12[J].Int Immunol, 2000, 12(6) :909-914.
10Smyth MJ, Godfrey DI. NKT cells and tumor immunity: a double edged sword[J]. Nat Immunol, 2000, 1(6) :459-460.
